Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ALX-804-822-C100 - Provider product page
- Provider
- Enzo Life Sciences
- Proper citation
- Enzo Life Sciences Cat#ALX-804-822-C100, RRID:AB_2051037
- Product name
- CD3 (human) monoclonal antibody (TR66)
- Antibody type
- Monoclonal
- Antigen
- Purified from natural sources
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- TR66
- Vial size
- 100 μg
- Storage
- 0
- Handling
- For long term storage, aliquot and freeze at -20¡C. Avoid freeze/thaw cycles.
Submitted references T cell fitness determined by signal strength.
CARMA1 is a critical lipid raft-associated regulator of TCR-induced NF-kappa B activation.
T lymphocyte costimulation mediated by reorganization of membrane microdomains.
FLIP prevents apoptosis induced by death receptors but not by perforin/granzyme B, chemotherapeutic drugs, and gamma irradiation.
The use of hybrid hybridomas to target human cytotoxic T lymphocytes.
Gett AV, Sallusto F, Lanzavecchia A, Geginat J
Nature immunology 2003 Apr;4(4):355-60
Nature immunology 2003 Apr;4(4):355-60
CARMA1 is a critical lipid raft-associated regulator of TCR-induced NF-kappa B activation.
Gaide O, Favier B, Legler DF, Bonnet D, Brissoni B, Valitutti S, Bron C, Tschopp J, Thome M
Nature immunology 2002 Sep;3(9):836-43
Nature immunology 2002 Sep;3(9):836-43
T lymphocyte costimulation mediated by reorganization of membrane microdomains.
Viola A, Schroeder S, Sakakibara Y, Lanzavecchia A
Science (New York, N.Y.) 1999 Jan 29;283(5402):680-2
Science (New York, N.Y.) 1999 Jan 29;283(5402):680-2
FLIP prevents apoptosis induced by death receptors but not by perforin/granzyme B, chemotherapeutic drugs, and gamma irradiation.
Kataoka T, Schröter M, Hahne M, Schneider P, Irmler M, Thome M, Froelich CJ, Tschopp J
Journal of immunology (Baltimore, Md. : 1950) 1998 Oct 15;161(8):3936-42
Journal of immunology (Baltimore, Md. : 1950) 1998 Oct 15;161(8):3936-42
The use of hybrid hybridomas to target human cytotoxic T lymphocytes.
Lanzavecchia A, Scheidegger D
European journal of immunology 1987 Jan;17(1):105-11
European journal of immunology 1987 Jan;17(1):105-11
No comments: Submit comment
No validations: Submit validation data